No gene acts alone: interacting variants and protein partnerships can worsen, mask or even rescue disease risk, demanding ...

A brand-new paper has just been published that claims to challenge the century-old dogma that Alzheimer’s disease is ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle ...

Researchers at the German Cancer Research Center and Heidelberg University showed that cells regulated inflammation through ...

A deep dive into the Fc–FcR axis as a therapeutic anchor in autoimmune disease, examining immune signaling and drug ...

As 'Strongest Berberine for Weight Loss,' 'Best Berberine Supplement,' and 'Nature's Ozempic' Search Phrases Peak in 2026, ...

January 2026 Consumer Search Analysis Examines How Shoppers Evaluate Single-Ingredient vs Multi-Ingredient Berberine ...

Cancer evolves through layers of change: mutations in DNA, shifts in gene regulation, altered cell behaviour, and dynamic ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

Sickle cell anemia is the world's most common genetic disorder. It causes the red blood pigment hemoglobin to crystallize, ...

This important study, which tackles the challenge of analyzing genome integrity and instability in unicellular pathogens by introducing a novel single-cell genomics approach, presents compelling ...

Dual-payload ADCs are gaining traction, offering opportunities to overcome the tumour heterogeneity and resistance challenges ...